AJIC: American Journal of Infection Control
Volume 37, Issue 1 , Pages 43-48 , February 2009

A large outbreak of Trichophyton tonsurans among health care workers in a pediatric hospital

  • Jodi Shroba, RN, MSN, CPNP

      Affiliations

    • Department of Nursing, Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    • Corresponding Author InformationAddress correspondence to Jodi Shroba RN, MSN, CPNP, Children's Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, MO 64108.
  • ,
  • Cindy Olson-Burgess, RN, CIC

      Affiliations

    • Division of Infection Control, Children's Mercy Hospitals and Clinics, Kansas City, Missouri
  • ,
  • Barry Preuett, BS

      Affiliations

    • Division of Pediatric Clinical Pharmacology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri
  • ,
  • Susan M. Abdel-Rahman, PharmD

      Affiliations

    • Division of Pediatric Clinical Pharmacology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri
    • School of Medicine, University of Missouri Kansas City, Kansas City, Missouri

References 

  1. Bronson D, Desai D, Foley S. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago. J Am Acad Dermatol. 1983;8:322–330
  2. Williams JV, Honig PJ, McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner city school children. Pediatrics. 1995;96:265
  3. Abdel-Rahman S, Simon S, Wright K, Ndjountche L, Gaedigk A. Tracking Trichophyton tonsurans through a large urban child care center: defining infection prevalence and transmission patterns by molecular strain typing. Pediatrics. 2006;118:2365–2373
  4. Poisson DM, Rousseau D, Defo D, Esteve E. Outbreak of tinea corporis gladiatorum, a fungal skin infection due to Trichophyton tonsurans, in a French high-level judo team. Eur Surveill. 2005;10:187–190
  5. Nyawalo JO, Bwire M. Single-dose and intermittent griseofulvin regimens in the treatment of tinea capitis in Kenya. Mycoses. 1988;31:229–234
  6. Pomeranz AJ, Sabnis SS, McGrath GJ, Esterly NB. Asymptomatic dermatophyte carriers in the households of children with tinea capitis. Arch Pediatr Adolesc Med. 1999;153:483–486
  7. Ergin S, Ergin C, Erdogan BS, Kaleli I, Evliyaoglu D. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans. Clin Exp Dermatol. 2006;31:212–214
  8. Viguié-Vallanet C, Serre M, Masliah L, Tourte-Schaefer C. Épidémie de tiegnes à Trichophyton tonsurans dans une école maternelle de la région parisienne. Ann Dermatol Venereol. 2005;132:432–438
  9. Shiraki Y, Hiruma M, Hirose N, Sugita T, Ikeda S. A nationwide survey of Trichophyton tonsurans infection among combat sport club members in Japan using a questionnaire form and the hairbrush method. J Am Acad Dermatol. 2006;54:622–626
  10. Hedayati MT, Afshar P, Shokohi T, Aghili R. A study on tinea gladiatorum in young wrestlers and dermatophyte contamination of wrestling mats from Sari-Iran. Br J Sports Med. 2007;41:332–334
  11. Arnow P, Houchins BA, Pugliese G. An outbreak of tinea corporis in hospital personnel caused by a patient with Trichophyton tonsurans infection. Pediatr Infect Dis J. 1991;10:355–359
  12. Drusin L, Ross B, Rhodes K, Krause A, Scott R. Nosocomial ringworm in a neonatal intensive care unit: a nurse and her cat. Infect Control Hosp Epidemiol. 2000;21:605–607
  13. Kane J, Leavitt E, Summerbell RC, Krajden S, Kasatiya SS. An outbreak of Trichophyton tonsurans dermatophytosis in a chronic care institution for the elderly. Eur J Epidemiol. 1988;4:144–149
  14. Lewis S, Lewis B. Nosocomial transmission of Trichophyton tonsurans tinea corporis in a rehabilitation hospital. Infect Control Hosp Epidemiol. 1997;18:322–325
  15. Shah P, Krajden S, Kane J, Summerbell R. Tinea corporis caused by Microsporum canis: report of a nosocomial outbreak. Eur J Epidemiol. 1988;4:33–38
  16. Wood B, Rademaker M. Nosocomial Trichophyton tonsurans in a long-stay ward. N Z Med J. 1997;110:277–278
  17. Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev. 2000;13:332–370
  18. Gaedigk A, Gaedigk R, Abdel-Rahman SM. Genetic heterogeneity in the ribosomal RNA gene locus of Trichophyton tonsurans.. J Clin Microbiol. 2003;41:5478–5487
  19. Bhathena A, Gaedigk R, Abdel-Rahman SM. Characterization of the ALP1 gene locus of Trichophyton tonsurans. Mycopathologia. 2005;160:265–272
  20. Occupational Safety and Health Administration, US Department of Labor. Determination of work-relatedness, 1904.5. Available from: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=9636. Accessed November 29, 2006.
  21. Bolyard E, Tablan O, Williams W, Pearson ML, Shapiro CN, Deitchmann SD. Guideline for infection control in health care personnel, 1998. Am J Infect Control. 1998;26:289–354
  22. American Academy of Pediatrics . Tinea capitis and tinea corporis. In:  Pickering LK editors. 2006 Red Book: Report of the Committee on Infectious Diseases. 27th ed.. Elk Grove Village IL: American Academy of Pediatrics; 2006;p. 654–658
  23. Suh DC, Fallon-Friedlander S, Raut M, Chang J, Vo L, Shin HC, et al. Tinea capitis in the United States: diagnosis, treatment, and costs. J Am Acad Dermatol. 2006;55:1111–1112
  24. Gupta A, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol. 2001;18:433–438
  25. Gupta A, Cooper E, Montero-Gei F. The use of fluconazole to treat superficial fungal infections in children. Dermatol Clin. 2003;21:537–542
  26. Hospital Infection Control Practices Advisory CommitteeCenters for Disease Control and PreventionPublic Health ServiceUS Department of Health and Human Services. Guideline for isolation precautions in hospitals. Part II: recommendations for isolation precautions in hospitals. Am J Infect Control. 1996;24:32–52

 Supported in part by a grant from the National Institutes of Health (R21 AR053234). The authors have no conflicts of interest to report.

PII: S0196-6553(08)00168-5

doi: 10.1016/j.ajic.2007.11.008

AJIC: American Journal of Infection Control
Volume 37, Issue 1 , Pages 43-48 , February 2009